Network updates

Previously called Pin Points

In this section we share clinical and practice operations updates from Pinnacle and the wider health sector. Use the search box and filters to help find what you’re looking for.

Have an update you’d like to share? Email us.

Limited Bicillin supplies: Use Benzetacil for people over 13

Te Whatu Ora | Health NZ is asking services to preserve limited Bicillin L-A supplies for children aged 13 and under receiving rheumatic fever prophylaxis. Practices should transition eligible people over 13 to Benzetacil as soon as possible, order Benzetacil if needed, and contact their supplier to return excess Bicillin stock for redistribution.

Health NZ flu vaccination campaign: Practices may see increased demand

Te Whatu Ora | Health NZ has contacted around 300,000 people, including people in Te Manawa Taki, encouraging them to get their flu vaccination amid high levels of influenza-related illness and winter pressure on health services. Practices may see increased patient enquiries and vaccination bookings as a result.

Change to referral process for outreach immunisation services

Te Whatu Ora has introduced BPAC referrals for referring pēpi and tamariki between 6 weeks to 6 years to the Outreach Immunisation Service (OIS). Practices can now refer directly to Outreach Immunisation Services using the familiar BPAC referral function within their Practice Management System (PMS).

Measles case confirmed in Manawatū – undetected cases possible

A measles case has been confirmed in Palmerston North with no identified source, meaning undetected cases in the community are possible. Clinicians should be alert for measles symptoms, particularly in people who spent time in Palmerston North from 4–18 July or Wellington on 11–12 July, and check current locations of interest. Suspected cases should be isolated, tested by PCR and notified to the local Medical Officer of Health without waiting for test results.

Change in special authority criteria for diabetes medicines

PHARMAC is changing the Special Authority criteria for empagliflozin and GLP-1 agonists, removing cardiovascular or renal risk as a requirement and widening access based primarily on HbA1c control and treatment pathways. Practices are encouraged to familiarise themselves with the new criteria, ensure required treatment trials are documented, and note that existing funded patients will retain access.

Connecting primary care professionals with workforce development opportunities

Now ready for your funding applications, Te Manawa Taki | Midlands Workforce Hub has been established to support the development of our primary and community healthcare workforce by making training, education, and funding opportunities easier to find and access. See what is available and what is in the pipeline.

Fees review process and Stable Fees Policy

Te Whatu Ora | Health New Zealand has introduced a Stable Fees Policy for standard GP consultations as part of the 2026/27 funding agreement. Standard consultation fees are expected to remain at 8 June 2026 levels, unless an approved exception is granted. Practices are encouraged to familiarise themselves with the policy and review the full guidance on the Pinnacle website.